Eosinophilic fasciitis (Shulman syndrome)

Cutis

Volumn 75, Issue 4, 2005, Pages 228-232

  Carneiro, Sueli ^a,b,d   Brotas, Arles ^a,b   Lamy, Fabrício ^a,b   Lisboa, Flávia ^a,b   Lago, Eduardo ^a,b   Azulay, David ^a,b   Cuzzi, Tulia ^a,c   Ramos e Silva, Marcia ^a,b  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Institute of Dermatology   (Brazil)

^c Sector of Pathology   (Brazil)

^d NONE   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC POTASSIUM; PREDNISONE;

ADULT; ANAMNESIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; EOSINOPHILIC FASCIITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LABORATORY TEST; MALE; SCLERODERMA;

EID: 18244397954     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Shulman LE. Diffuse fasciite with hypergammaglobulinemia and eosinophilia: a new syndrome? J Rheumatol. 1974;1(suppl 1):46-49.
2. Rodnan GP, DiBartolomeo A, Medsger TA Jr. Proceedings: eosinophilia fasciitis. report of six cases of a newly recognized scleroderma-like syndrome. Arthritis Rheum. 1975;18:525.
3. Helfman T, Falanga V. Eosinophilic fasciitis. Clin Dermatol. 1974;12:449-455.
4. Le Roy EC. Scleroderma (systemic sclerosis). In: Kelly WN, Harris ED Jr, Ruddy S, et al, eds. Textbook of Rheumatology. Philadelphia, Pa: WB Saunders; 1981:1218-1228.
5. Leiferman KM. Cutaneous eosinophilic diseases. In: Eisen AZ, Wolff K, Freedberg IM, et al, eds. Fitzpatrick's Dermatology in General Medicine. 5th ed. New York, NY: McGraw-Hill; 1999:1129-1137.
6. Doyle JA, Connolly SM, Winkelmann RK. Cutaneous and subcutaneous inflammatory sclerosis syndromes. Arch Dermatol. 1982;118:886-890.
7. Gray RG, Poppo MJ. Eosinophilic fasciitis: a scleroderma-like illness. JAMA. 1977;237:529-530.
8. Barnes L, Rodnan GP, Medsger TA, et al. Eosinophilic fasciitis: a pathologic study of twenty cases. Am J Pathol. 1979;96:493-517.
9. Yamada RM. Fasciíte eosinofílica: relato de caso. Rev Bras Rheumatol. 1997;37:172-174.
10. Odom R, James WD, Berger TG. Connective tissue diseases. In: Odom R, James WD, Berger TG, eds. Andrew's Diseases of the Skin. 9th ed. Philadelphia, Pa: Saunders; 2000:200-201.
11. Caperton EM, Hathaway DE, Dehner LP. Morphea, fasciitis, and scleroderma with eosinophilia: a broad spectrum of disease [abstract]. Arthritis Rheum. 1976;19:792-793.
12. Tuffanelli DL. Systemic sclerosis. In: Sontheimer RD, Provost TT, eds. Cutaneous Manifestations of Rheumatic Diseases. Baltimore, Md: Williams & Wilkins; 1998:115-140.
13. Eosinophilia myalgia syndrome associated with tryptophan. BMJ. 1990;301:387-388.
14. van Garsse LG, Boeykens PP. Two patients with eosinophilia myalgia syndrome associated with tryptophan. BMJ. 1990;301:21.
15. Belongia ES, Mayeno NA, Osterholm MT. The eosinophilia myalgia syndrome and tryptophan. Ann Rev Nutr. 1992;12:235-256.
16. Silver RM. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia. Curr Opin Rheumatol. 1993;5:802-808.
17. Falanga V, Medsger TA Jr. Frequency levels significance of blood eosinophilia in systemic sclerosis, localized scleroderma, and eosinophilic fasciitis. J Am Acad Dermatol. 1987;17:648-656.
18. Vazquez Botet M, Sanchez JL. The fascia in systemic scleroderma. J Am Acad Dermatol. 1980;3:36-42.
19. Lever WF, Lever GS. Connective tissue diseases. In: Lever WF, Lever GS, eds. Histopathology of the Skin. Philadelphia, Pa: Lippincott; 1990:494-522.
20. Clauw DJ. Environmentally associated rheumatic disease - miscellaneous disorders. In: Kippel JA, Dieppe PA, eds. Rheumatology. 2nd ed. London, England: Mosby; 1998:34.1-34.10.
21. Moutsopoulos HM, Webber BL, Pavlidis NA, et al. Diffuse fasciitis with eosinophilia. a clinicopathologic study. Am J Med. 1980;68:701-709.
22. Lakhanpal S, Ginsburg WW, Michet CJ, et al. Eosinophilic fasciitis, clinical spectrum and therapeutic response in 52 cases. Semin Arthritis Rheum. 1988;17:221-231.